Search results
A hemophilia drug that just won FDA approval pegs a one-time $3.5 million vial against several...
Quartz via Yahoo Finance· 2 years agoThere’s a new one-time treatment for Hemophilia B patients in the market, but it comes with an...
An OrbiMed-backed biotech launches with $85M and plans for a new kind of DNA medicine
BioPharma Dive via Yahoo Finance· 7 months agoWhen developing new medicines, drugmakers typically try to make treatments that are more effective,...
Pfizer (PFE) Posts Upbeat Data From Hemophilia Drug Study
Zacks via Yahoo Finance· 1 year agoData from a late-stage study shows that treatment with Pfizer's (PFE) experimental anti-TFPI...
A Colorado panel of medical and pharmacy experts will decide whose medicine to make affordable this...
Fortune via Yahoo Finance· 1 year agoCatherine Reitzel’s multiple sclerosis medication costs nearly $100,000 a year. Kris Garcia relies...
Gene therapy might cure sickle cell, but at a steep cost for patients, society
USA TODAY via Yahoo News· 7 months agoMyles Newsome has spent as many school days in the hospital as he has at his high school. In middle...
Kamada Ltd. (NASDAQ:KMDA) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoKamada Ltd. (NASDAQ:KMDA) Q4 2022 Earnings Call Transcript March 15, 2023 Operator: Greetings....
The Biggest Medical Breakthroughs of 2022
Gizmodo via Yahoo News· 1 year agoThe past year brought us inspiring advances in medical and health science, from new insights into devastating diseases like multiple sclerosis and lupus...
Q3 2023 Inovio Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 months agoParticipants Thomas Hong; IR; Inovio Pharmaceuticals, Inc. Jacqui Shea; President & CEO; Inovio Pharmaceuticals, Inc. Mike Sumner; Chief Medical Officer; Inovio Pharmaceuticals, Inc. Mark Twyman ...
